Vaccines For Immune Mediated Diseases
Patients with safe interceded incendiary ailments (IMID, for example, RA, IBD or psoriasis, are at augmented danger of contamination, in part in light of the malady itself, however for the most part in light of treatment with immunomodulatory or immunosuppressive medications. Regardless of their raised hazard for immunization preventable ailment, inoculation scope in IMID patients is shockingly low.
- Central nervous system-targeted & Tissue-specific autoimmunity
- Innate immunity and diabetes vaccines
- Vaccination strategy in patients with IMID
- Vaccine safety: impact on disease activity in IMID patients
- Vaccines for autoimmune skin disorders & neuropathies
- Vaccines for immunodeficiency diseases
Related Conference of Vaccines For Immune Mediated Diseases
March 10-11, 2021
4th International Conference on Vaccines, Immunization and Clinical Trials
Amsterdam, Netherlands
Vaccines For Immune Mediated Diseases Conference Speakers
Recommended Sessions
- Animal Vaccination
- Antibodies : Engineering & Therapeutics
- Bacterial Vaccines
- Cancer Vaccines & Immunotherapy
- Childhood & Maternal Vaccines
- DNA Based Vaccines
- Geriatric Immunization
- HIV/AIDS Vaccines
- HPV & Hepatitis Vaccines
- Human Vaccines-Infectious & Non-Infectious
- Immunizations & Bioterrorism
- Modern Technologies In Vaccine Discovery & Development
- Mosquito-Borne Diseases-Vaccines
- Plant Derived Vaccines
- Protein Based Vaccines
- Toxoid Vaccines
- Travel Immunization
- Vaccine Adjuvants & Delivery Technologies
- Vaccine Industry
- Vaccine Safety & Efficacy
- Vaccines & Immunizations
- Vaccines For Immune Mediated Diseases
- Vaccines For Pregnant Women & Neonates
- Vaccines For Unconventional Diseases
- Vaccines Preclinical & Clinical Trials
- Viral Vaccines
Related Journals
Are you interested in
- Animal Models and Biological Research - Vaccines R&D 2021 (Netherlands)
- Bioinformatics and Biotherapeutics - Vaccines R&D 2021 (Netherlands)
- Biomarkers and Case Reports - Vaccines R&D 2021 (Netherlands)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2021 (Spain)
- Cancer, Malaria & TB Vaccines - Vaccines World 2021 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2021 (Spain)
- Clinical Trials, Research and Development - Vaccines R&D 2021 (Netherlands)
- Combination & Conjugate Vaccines - Vaccines World 2021 (France)
- Coronavirus (Covid 19) and Next Generation Vaccines - Vaccines R&D 2021 (Netherlands)
- COVID-19 Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- DNA & Synthetic Vaccines - Vaccines World 2021 (France)
- DNA Vaccines - Euro Vaccines 2021 (Spain)
- Emerging and Infectious Diseases - Vaccines R&D 2021 (Netherlands)
- Hepatitis Vaccines - Euro Vaccines 2021 (Spain)
- HIV Vaccines - Vaccines World 2021 (France)
- HIV Vaccines and Policy Issues - Vaccines R&D 2021 (Netherlands)
- HIV/AIDS Vaccines - Euro Vaccines 2021 (Spain)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2021 (Spain)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2021 (Spain)
- Immunization and Bioprocessing - Vaccines R&D 2021 (Netherlands)
- Immuno-Oncology and Immunotherapy - Vaccines R&D 2021 (Netherlands)
- Immunology/Animal Models - Euro Vaccines 2021 (Spain)
- Influenza and Respiratory Vaccines - Vaccines R&D 2021 (Netherlands)
- Live Attenuated and Inactivated Vaccines - Vaccines R&D 2021 (Netherlands)
- Manufacturing, Production, and Delivery Technologies - Vaccines R&D 2021 (Netherlands)
- Mucosal Vaccines - Euro Vaccines 2021 (Spain)
- New Trends in Vaccines Development - Vaccines World 2021 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2021 (Spain)
- Pediatric Vaccination - Vaccines World 2021 (France)
- Pediatric Vaccines - Vaccines World 2021 (France)
- Public Health and Patient Safety - Vaccines R&D 2021 (Netherlands)
- RDT in Antibiotic Research - Vaccines World 2021 (France)
- Regulatory Licensing and Scientific Affairs - Vaccines R&D 2021 (Netherlands)
- Side-effects of Vaccines - Vaccines World 2021 (France)
- Subunit/Conjugate and Toxoid Vaccines - Vaccines R&D 2021 (Netherlands)
- Toxoid Vaccines - Vaccines World 2021 (France)
- Translational Research on Pandemic Outbreaks - Vaccines R&D 2021 (Netherlands)
- Vaccine Adjuvants - Euro Vaccines 2021 (Spain)
- Vaccine Adjuvants and Antibody Engineering - Vaccines R&D 2021 (Netherlands)
- Vaccine Hesitancy and Health Literacy - Vaccines R&D 2021 (Netherlands)
- Vaccine Production & Development - Vaccines World 2021 (France)
- Vaccine Research & Development - Euro Vaccines 2021 (Spain)
- Vaccine Safety & Efficacy - Vaccines World 2021 (France)
- Vaccine Safety and Efficacy - Vaccines R&D 2021 (Netherlands)
- Vaccines - Vaccines World 2021 (France)
- Vaccines Against Infectious Diseases - Vaccines World 2021 (France)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Business Development - Euro Vaccines 2021 (Spain)
- Vaccines for Older Adults - Euro Vaccines 2021 (Spain)
- Vaccines for Pregnant Women - Vaccines World 2021 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2021 (Spain)
- Vaccines for Unconventional Diseases - Vaccines World 2021 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2021 (Spain)
- Vaccines Manufacturing Technologies - Vaccines World 2021 (France)
- Vaccines Research and Clinical Trails - Vaccines World 2021 (France)
- Vaccines safety & Efficacy - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines - Euro Vaccines 2021 (Spain)
- Veterinary Vaccines and Animal Health - Vaccines R&D 2021 (Netherlands)
- Viral Vaccines and Bacterial Vaccines - Vaccines R&D 2021 (Netherlands)
- Virology and Antiviral Drugs - Vaccines R&D 2021 (Netherlands)
- Zika Virus Vaccines - Vaccines World 2021 (France)